Clinical trial · Observational
Locus of Control and Spirituality in Palliative Care Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Primary Objectives: 1. To determine whether the degree of spirituality/religiosity as determined by the Duke University Religion Index and Functional Assessment of Chronic Illness Therapy-Spiritual Well Being Scale (FACIT-Sp) correlates with internal locus of control as determined by the Locus of Control Scale. 2. To determine the relationships among spiritual-well being, religiosity, hope, depression, and culture, socioeconomic status, and gender in a palliative care setting. 3. To determine if hope and depression in palliative care patients are affected by the degree of intrinsic and extrinsic spirituality/religiosity. 4. To determine if patients who believe in predestination correlate with decreased locus of control, but improved quality of life and degree of religiosity.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaire | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Palliative Care Clinic Patients
- description
- Department of Symptom Control and Palliative Care Center Patients
- interventionNames
- Behavioral: Questionnaire
Primary outcomes (1)
- measure
- Determination of Spirituality/Religiosity in Correlation With Internal Locus of Control.
- timeFrame
- 40 minutes to complete questionnaires.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age \> 17 years (surveys have not been validated in minors) 2. Expected survival \> 6 weeks 3. Patients experiencing acute side effects from chemotherapy (mucositis, emesis, or severe grade 2-3 neuropathy) are not eligible 4. No clinical evidence of cognitive failure, with normal Mini Mental State Examination (MMSE). A score of 24 is considered normal 5. Only new patients presenting to the Department of Symptom Control and Palliative Care Center Exclusion Criteria: 1\) N/A
References
Publications (0)
Data not yet available